Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kenakin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Autonomic Pharmacology|March 22, 2001
The relative importance of the time-course of receptor occupancy and response decay on apparent antagonist potency in dynamic assaysM Corsi, T Kenakin
British Journal of Pharmacology|December 17, 2013
The tail wags the dog: possible mechanism for reverse allosteric control of ligand-activated channelsE Vardy, T Kenakin
Biochemical Pharmacology|June 29, 1995
On the importance of the "antagonist assumption" to how receptors express themselvesT Kenakin, P Morgan, M Lutz
Trends in Pharmacological Sciences|July 1, 1990
Drug and tissue factors both confound KA measurementsT Kenakin, P H Morgan, M Lutz
European Journal of Pharmacology|January 22, 1982
Irreversible blockade of responses to a partial agonist acting at the histamine H1-receptorD Cook, D Iwanow, T Kenakin, et al.
Current Protocols in Pharmacology|October 6, 2011
β-Adrenoceptor assaysT Kenakin, J M Lenhard, M A Paulik
Journal of Pharmacological and Toxicological Methods|October 18, 2000
Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptorS L Armour, S Foord, T Kenakin, et al.
Molecular Pharmacology|November 28, 2000
The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonistsC Watson, G Chen, P Irving, et al.
Molecular Pharmacology|January 5, 2000
Use of constitutive G protein-coupled receptor activity for drug discoveryG Chen, J Way, S Armour, et al.
Journal of Pharmacological and Toxicological Methods|October 18, 2000
Constitutive receptor systems for drug discoveryG Chen, C Jayawickreme, J Way, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Autonomic Pharmacology|March 22, 2001
The relative importance of the time-course of receptor occupancy and response decay on apparent antagonist potency in dynamic assaysM Corsi, T Kenakin
British Journal of Pharmacology|December 17, 2013
The tail wags the dog: possible mechanism for reverse allosteric control of ligand-activated channelsE Vardy, T Kenakin
Biochemical Pharmacology|June 29, 1995
On the importance of the "antagonist assumption" to how receptors express themselvesT Kenakin, P Morgan, M Lutz
Trends in Pharmacological Sciences|July 1, 1990
Drug and tissue factors both confound KA measurementsT Kenakin, P H Morgan, M Lutz
European Journal of Pharmacology|January 22, 1982
Irreversible blockade of responses to a partial agonist acting at the histamine H1-receptorD Cook, D Iwanow, T Kenakin, et al.
Current Protocols in Pharmacology|October 6, 2011
β-Adrenoceptor assaysT Kenakin, J M Lenhard, M A Paulik
Journal of Pharmacological and Toxicological Methods|October 18, 2000
Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptorS L Armour, S Foord, T Kenakin, et al.
Molecular Pharmacology|November 28, 2000
The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonistsC Watson, G Chen, P Irving, et al.
Molecular Pharmacology|January 5, 2000
Use of constitutive G protein-coupled receptor activity for drug discoveryG Chen, J Way, S Armour, et al.
Journal of Pharmacological and Toxicological Methods|October 18, 2000
Constitutive receptor systems for drug discoveryG Chen, C Jayawickreme, J Way, et al.
Pageof 4